Khara Rahul 4

What Happened
Rahul Khara, Chief Legal Officer of Disc Medicine (IRON), exercised stock options and sold the resulting shares under a pre-established trading plan. On 2026-06-26 she exercised 851 options (exercise price $14.69) and sold those 851 shares at $75.00 each (proceeds $63,825). On 2026-06-29 she exercised 1,649 options (exercise price $14.69) and sold those 1,649 shares at $75.00 each (proceeds $123,675). Total shares exercised and sold: 2,500; total sale proceeds: $187,500; total cash paid to exercise: $36,725; approximate gross proceeds after exercise (before taxes/fees): $150,775.

Key Details

• Transaction dates and prices:
  • 2026-06-26: exercised 851 options at $14.69; sold 851 shares at $75.00.
  • 2026-06-29: exercised 1,649 options at $14.69; sold 1,649 shares at $75.00.
• Filing: Form 4 filed 2026-06-30 reporting the above transactions (filing shows trade dates 6/26 and 6/29).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnotes:
  • Transactions were effected pursuant to a Rule 10b5-1 trading plan adopted March 19, 2026.
  • The underlying options were fully vested and exercisable as of the filing date.
• Derivative entries: The filing also shows derivative “disposed” line items at $0, which reflect the option exercises/settlements tied to the transactions.

Context
This was an exercise of vested options followed by immediate open-market sales (common cashless-exercise or sell-to-cover pattern) executed under a 10b5-1 plan. Such transactions are typically routine mechanisms for insiders to realize gains from vested awards and, on their own, do not necessarily signal a change in the insider’s view of the company.